DDX3X Promotes Rotavirus Infection and Serves as an Antiviral Target
Transboundary and Emerging Diseases · 2025
DOI: 10.1155/tbed/5822897 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transboundary and Emerging Diseases, 2025. Verfasst von Pengfei Hao und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory of Zoonosis Research, Ministry of Education, …. Hauptthemen laut MEDLINE: DEAD-box RNA Helicases, Rotavirus, Rotavirus Infections, Antiviral Agents. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation, Chinese Academy of Medical Sciences, National Natural Science Foundation of China.
Abstract (Originalsprache)
Rotavirus (RV) is a significant zoonotic pathogen primarily causing severe diarrheal disease in humans and animals, posing substantial risks to global public health and livestock industries. VP4 is one of the outer capsid proteins of RV and plays a crucial role in RV attachment and internalization. Additionally, it is also involved in replication and immune responses during RV infection; however, related studies are still limited. Here, a comprehensive analysis of the RV VP4 interactome was conducted, and DDX3X, one of six DExD/H helicase family members identified as interacting with VP4, potentially plays a crucial role in RV infection. Silencing DDX3X inhibits RV infection, whereas its overexpression facilitates RV infection. Further research demonstrated that VP4 interacts with DDX3X and the enzymatic activity of DDX3X was found to contribute to promote RV replication. Additionally, a drug screening study based on the VP4 interactome identified RK‐33, a potent inhibitor of DDX3X, as the most effective candidate compound for inhibiting RV. In conclusion, VP4 interacts with DDX3X and the enzymatic activity of DDX3X is crucial for RV replication. The DDX3X inhibitor RK‐33 exhibits significant inhibitory effects on RV infection. This study highlights the important roles of DDX3X in RV infection, offering potential candidate drugs for RV and expanding our understanding of its mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory of Zoonosis Research, Ministry of Education, College of Basic Medical Science, Jilin University, Changchun, China.
- State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, China.
- Research Unit of Key Technologies for Prevention and Control of Virus Zoonoses, Chinese Academy of Medical Sciences, Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
ORCID-Profile: Pengfei Hao, Jian Wang, Guoqing Wang, Chang Li
Förderung
- China Postdoctoral Science Foundation
- Chinese Academy of Medical Sciences
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Hao, P., Liu, Y., Cui, C., Li, L., Qu, Q., Shang, L., Chen, J., Jiang, Y., Yin, R., Wang, J., Wang, G., & Li, C. (2025). DDX3X Promotes Rotavirus Infection and Serves as an Antiviral Target. Transboundary and Emerging Diseases. https://doi.org/10.1155/tbed/5822897
Vancouver
Hao P, Liu Y, Cui C, Li L, Qu Q, Shang L, et al. DDX3X Promotes Rotavirus Infection and Serves as an Antiviral Target. Transboundary and Emerging Diseases. 2025. doi:10.1155/tbed/5822897
BibTeX
@article{Hao2025,
author = {Hao, Pengfei and Liu, Yuchen and Cui, Chunmei and Li, Letian and Qu, Qiaoqiao and Shang, Limin and Chen, Jing and Jiang, Yuhang and Yin, Ronglan and Wang, Jian and Wang, Guoqing and Li, Chang},
title = {DDX3X Promotes Rotavirus Infection and Serves as an Antiviral Target},
journal = {Transboundary and Emerging Diseases},
year = {2025},
doi = {10.1155/tbed/5822897}
}
EUVIMED